Defining the potency of amikacin against <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Pseudomonas aeruginosa</em>, and <em>Acinetobacter baumannii</em> derived from Chinese hospitals using CLSI and inhalation-based breakpoints
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.